+924.9%
MRNA vs LYB
+47.1%
+877.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LYB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.5% | -2.1% | -4.4% | -6.8% |
| 7D | +8.4% | -5.7% | +14.1% | +7.6% |
| 30D | +28.8% | +4.6% | +24.2% | +29.0% |
| 3M | +329.2% | +5.5% | +323.7% | +330.1% |
| 6M | +416.9% | -19.1% | +436.0% | +426.1% |
| YTD | +718.8% | +47.1% | +671.7% | +622.0% |
| 1Y | +924.9% | +49.0% | +875.9% | +803.7% |
| All | +924.9% | +47.1% | +877.8% | +803.7% |
Cumulative growth
Daily Returns
Daily percentage return beside LYB.
Daily Out/Under-Performance
Portfolio return minus LYB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LYB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LYB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling